Orchestra BioMed Holdings, Inc. Increase (Decrease) in Prepaid Expense
Orchestra BioMed Holdings, Inc. (OBIO) reported Increase (Decrease) in Prepaid Expense of $77.25 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-01-25.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2023-01-25
- Orchestra BioMed Holdings, Inc. increase (decrease) in prepaid expense for the quarter ending 2022-12-31 was -$13.42K.
- Orchestra BioMed Holdings, Inc. increase (decrease) in prepaid expense for the quarter ending 2022-09-30 was $100.92K.
- Orchestra BioMed Holdings, Inc. increase (decrease) in prepaid expense for the quarter ending 2022-06-30 was -$34.88K.
- Orchestra BioMed Holdings, Inc. increase (decrease) in prepaid expense for the quarter ending 2022-03-31 was $24.63K, a 23.52% increase year-over-year.
- Orchestra BioMed Holdings, Inc. increase (decrease) in prepaid expense for fiscal 2022 was $77.25K.
- Orchestra BioMed Holdings, Inc. increase (decrease) in prepaid expense for fiscal 2021 was -$75.81K.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 4 month | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 7 month | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 12 month |
|---|---|---|---|---|---|---|
| 2022-12-31 | -$13.42K derived: 10-K 12 month − 10-Q 9 month · filed 2023-01-25 | $87.50K derived: sum of 2 quarters · filed 2023-01-25 | $52.63K derived: sum of 3 quarters · filed 2023-01-25 | $77.25K 10-K · filed 2023-01-25 | ||
| 2022-09-30 | $100.92K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $66.05K derived: sum of 2 quarters · filed 2022-11-14 | $90.67K 10-Q · filed 2022-11-14 | $56.17K derived: sum of 4 quarters · filed 2023-01-25 | ||
| 2022-06-30 | -$34.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$10.25K 10-Q · filed 2022-08-15 | -$44.75K derived: sum of 3 quarters · filed 2023-01-25 | -$69.25K derived: sum of 4 quarters · filed 2023-01-25 | ||
| 2022-03-31 | $24.63K 10-Q · filed 2022-05-13 | -$9.88K derived: sum of 2 quarters · filed 2023-01-25 | -$34.38K derived: sum of 3 quarters · filed 2023-01-25 | -$71.12K derived: sum of 4 quarters · filed 2023-01-25 | ||
| 2021-12-31 | -$34.50K derived: 10-K 12 month − 10-Q 9 month · filed 2023-01-25 | -$59.00K derived: sum of 2 quarters · filed 2023-01-25 | -$95.75K derived: sum of 3 quarters · filed 2023-01-25 | -$75.81K 10-K · filed 2023-01-25 | ||
| 2021-09-30 | -$24.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$61.25K derived: sum of 2 quarters · filed 2022-11-14 | -$41.31K 10-Q · filed 2022-11-14 | |||
| 2021-06-30 | -$36.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$16.81K 10-Q · filed 2022-08-15 | ||||
| 2021-03-31 | $19.94K 10-Q · filed 2022-05-13 | |||||
| 2020-12-31 | $122.48K 10-K/A · filed 2022-03-31 | |||||
| 2020-09-30 | $160.13K 10-Q/A · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |